[Fluconazole in the treatment of dermatomycoses. Clinical experience].
Twenty patients suffering from dermatomycosis have been treated with fluconazole at the dose of 50 mg/daily for 20 days. These patients (10 M + 10 F) were aged 36 years on average (range 17-65 years). And were suffering from the following: Tinea pedis (3 cases), Tinea cruris (1 case), Tinea corporis (9 cases), Tinea versicolor (3 cases), Candidiasis (5 cases). One patient was suffering from Tinea on two different body sites. 19 patients finished the treatment and reported a complete clinical and mycological healing either at the end of the therapy on at follow-up visits. One patient, who was already suffering from gastritis, had to interrupt the therapy early due to abdominal pain. General safety was excellent.
Zucchi
A
A
Istituto di Clinica Dermosifilopatica, Università di Parma.
De Panfilis
G
G
Allegra
F
F
D000293:Adolescent; D000328:Adult; D000368:Aged; D003881:Dermatomycoses / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged
D015725:Fluconazole
Il fluconazolo nel trattamento delle epidermomicosi. Esperienze cliniche.